leisure time -WSS

leisure time

author：knowledge 2025-08-19 20:44:58 - browse：3

STAT

There’s nothing better than a beautiful spring day after a long, cold winter. But there’s nothing worse than having that day ruined by the sneezing, sniffling, and itching that come with seasonal allergies.

Scientists don’t actually completely understand why we get seasonal allergies. The best estimation is that they’re an immune response to toxins in the natural environment that pollen also happens to trigger. That immune response begins with the production of IgE antibodies to combat the pollen. The antibodies link up with mast cells, and together they’re a ticking time bomb. When more allergens come along, they activate all those horrible symptoms.

In the new episode of “Boddities,” we dive into how this response happens, and what you can do about it to ease the symptoms and enjoy the season.

Watch other “Boddities” episodes:

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

Previous article： In Memoriam: Notable people who died in 2023
Next article： Alnylam reports growth in sales of rare disease treatments

WSS

Biotech startup Celsius cuts 75% of staff ahead of first trial start

The a glaring gap in research on serious mental illness and primary care

Study links childhood stress with decline in older age

Group behind ProMed defends move to subscription

An inside look at PIPEs, biotech's buzzy new financing tool

Physicians aren't 'burning out.' They're suffering from moral injury

hotspot

leisure time

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

knowledge

Peter Hotez and the public health issue of online harassment

Kenai launches with $82 million for Parkinson’s stem cell therapy

Hepatitis C has a cure — but many Americans still lack access to it

FogPharma raises $145 million in rare Series E round

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Hollywood unions extend contract negotiations for actors

ALS groups 'won't be played again' by the FDA, drug sponsors

Dobbs anniversary: the lost opportunity of abortion as health care

FDA does about

leisure time

H.R. 3 is the wrong path to lower drug costs

RSV vaccines may be linked to small increased risk of developing GBS

The cancer stories no one wants to hear

FDA does about

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How to address the problem of discarded donor organs

leisure time

focus

hotspot

explore